항체 및 단백질공학 연구실

1) Innovative Platform Technology Development: We focus on developing groundbreaking platform technologies for efficient discovery of novel biomedical proteins, including antibodies. 2) Targeted Antibody Discovery: We specialize in identifying and developing antibodies that target antigens associated with conditions like cancer, inflammation, autoimmune diseases, and infectious diseases. 3) Advancement and Engineering of Therapeutic Proteins: Our research involves the directed evolution of therapeutic proteins to achieve remarkable enhancements in efficacy, serum stability, and safety, surpassing the limitations of currently developed antibodies. Recognizing the constraints inherent to existing antibodies, we undertake extensive protein engineering research to further transcend these boundaries. 4) Expansion of Therapeutic Modalities: We are initiating research into immune cell-engaging bispecific antibodies and antibody-drug conjugates to diversify the therapeutic modalities using antibodies.